XTL Biopharmaceuticals Ltd.

(XTLB) Trade

By |

Profile

XTL Biopharmaceuticals Ltd is engaged in the field of healthcare. It is a pharmaceutical manufacturer, with a focus on acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE). hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.

Contact Information

Website: www.xtlbio.com
Email: info@xtlbio.com
Main Phone: +972 99557080
Address: 5 HaCharoshet Street
City / Town: Raanana
Country: ISR
Postal Code: 43656

Issuer Information

Exchange: NSC
CEO: Josh Levine
Employees: 6
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 2.66 $ 0.46 (20.85%)
Last Price 2.66 Change $ 0.46 Change % 20.85 Tick N/A
Bid N/A Bid Size 0.00 Ask 2.58 Ask Size 200.00
Open 2.24 High 2.66 Low 2.24 Prev Close 2.20
Last Trade Volume 3,947 52 Wk Hi 3.94 52 Wk Low 1.55
Market Cap 13.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 5,142,057.00 EPS (TTM) 0.40 PE Ratio 5.50 Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 6 6 6 6
Low Target Price Estimate 6 6 6 6
Mean Target Price Estimate 6 6 6 6
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 12/02/15 12/02/15 12/02/15 12/02/15
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1